CDEK
← All organizations

Avant Immunotherapeutics

For profit
Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 2

First clinical trial

Apr 1, 2004

Last known activity

Nov 1, 2008

Acquired by Celldex Therapeutics on Jan 1, 2008

Timeline

1980s

  1. Jan 1, 1983

    Avant Immunotherapeutics— Founded

2000s

  1. Jan 1, 2008

    Celldex Therapeutics— Acquired By

2010s

  1. Mar 1, 2016

    Amarantus BioScience Holdings, Inc.— Acquired

Drugs by trial phase (5 distinct, 6 trials)

Indications

Studied for

Subsidiaries (1 direct, 1 total across the full acquisition tree)

Recent trials (3)

Details

Founded
Phillipsburg, NJ, US Jan 1, 1983
Last known activity
Nov 1, 2008